## Abstract ## BACKGROUND The authors determined the safety and efficacy of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor (G‐CSF) support in patients with hormone‐refractory prostate carcinoma. ## METHODS In the current multicenter, cooperative group study,
✦ LIBER ✦
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma : Results of Intergroup 0159/Cancer and Leukemia Group B 9480
✍ Scribed by Tim A. Ahles; James E. Herndon II; Eric J. Small; Nicholas J. Vogelzang; Alice B. Kornblith; Mark J. Ratain; Walter Stadler; David Palchak; M. Ernest Marshall; George Wilding; Daniel Petrylak; Jimmie C. Holland
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 86 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A Phase II study of estramustine, doceta
✍
William K. Oh; Susan Halabi; W. Kevin Kelly; Cary Werner; Paul A. Godley; Nichol
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 98 KB
👁 2 views
Quality of life among patients with Stag
✍
Jeffrey Peppercorn; James Herndon II; Alice B. Kornblith; William Peters; Tim Ah
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 176 KB
👁 2 views
## Abstract ## BACKGROUND The objective of this study was to compare the quality of life (QOL) after treatment among patients who had breast carcinoma with multiple positive lymph nodes. The patients were randomized to receive either high‐dose chemotherapy with autologous stem cell support (HDC) o